- Two biotechs raise a combined $556M in latest spurt of IPOs<figure><div><img src="https://imgproxy.divecdn.com/Ll8Kl4Xj3nHdTKBGSRbP6tU2Gjn-xo-ocHpjXqrNGQQ/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0xNDAxNzQ1Njc1LmpwZ…BioPharma Dive · 2mo ago↗ source
- Merck still sees ‘compelling’ outlook for Terns leukemia drug<figure><div><img src="https://imgproxy.divecdn.com/xfbigDwOXtNIbcSDIg7fJNLgHOwkgMuxa4LD4r3ON-0/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9TY3JlZW5zaG90XzIwMjQtMTItMTlfMTAzN…BioPharma Dive · 2mo ago↗ source
- UniQure, in ‘symbolic’ win, to seek UK approval of Huntington’s gene therapy<figure><div><img src="https://imgproxy.divecdn.com/KzTgmqusVHa-I1RJqlROBuSgo45i9g_dBOqQI8x92Z4/g:ce/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS80Y2QwNGU1YS1lNmEyLTQ2OWUtOGVkMS1mO…